Galapagos (Germany) Top Insiders
| GXE Stock | EUR 26.22 0.04 0.15% |
Galapagos employs about 9 people. The company is managed by 9 executives with a total tenure of roughly 21 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Examination of Galapagos' management performance can provide insight into the company performance.
| Elizabeth Goodwin Insider VP Relations |
| Andre Hoekema Insider Chief Board |
Galapagos |
Galapagos Management Team Effectiveness
The company has return on total asset (ROA) of (0.0303) % which means that it has lost $0.0303 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0843) %, meaning that it generated substantial loss on money invested by shareholders. Galapagos' management efficiency ratios could be used to measure how well Galapagos manages its routine affairs as well as how well it operates its assets and liabilities.Galapagos Workforce Comparison
Galapagos NV is rated below average in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 251,827. Galapagos adds roughly 9.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
The company has Profit Margin (PM) of (0.43) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.48) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.48. Galapagos NV Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Galapagos NV Price Series Summation is a cross summation of Galapagos price series and its benchmark/peer.
Galapagos Notable Stakeholders
A Galapagos stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Galapagos often face trade-offs trying to please all of them. Galapagos' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Galapagos' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Elizabeth Goodwin | VP Relations | Profile | |
| Andre Hoekema | Chief Board | Profile | |
| Michele MBA | Chief Board | Profile | |
| John Montana | Managing Argenta | Profile | |
| Walid AbiSaab | Chief Board | Profile | |
| Marieke Vermeersch | Head Communication | Profile | |
| Chantal Tasset | Head Devel | Profile | |
| Sofie Gijsel | Head Relations | Profile | |
| MBA MBA | COO Pres | Profile |
About Galapagos Management Performance
The success or failure of an entity such as Galapagos NV often depends on how effective the management is. Galapagos management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Galapagos management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Galapagos management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Galapagos NV, a clinical-stage biotechnology company, discovers, develops, and commercializes various small molecule medicines. The company was founded in 1999 and is headquartered in Mechelen, Belgium. GALAPAGOS operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 837 people.
Galapagos Workforce Analysis
Traditionally, organizations such as Galapagos use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Galapagos within its industry.Galapagos Manpower Efficiency
Return on Galapagos Manpower
| Revenue Per Employee | 53.9M | |
| Revenue Per Executive | 53.9M | |
| Net Loss Per Employee | 11.5M | |
| Net Loss Per Executive | 11.5M |
Complementary Tools for Galapagos Stock analysis
When running Galapagos' price analysis, check to measure Galapagos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galapagos is operating at the current time. Most of Galapagos' value examination focuses on studying past and present price action to predict the probability of Galapagos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galapagos' price. Additionally, you may evaluate how the addition of Galapagos to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |